4
Changes in Ownership
Anixa Biosciences Inc Filed Acc 0001493152-21-013453
Options or other derivatives
- Chief Executive Officer acquired 2,500,000 shares (grant or award)
- Chief Executive Officer returned 1,500,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
KUMAR AMIT · Chief Executive Officer
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-01 | Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) | +2,000,000 | 2,000,000 | D |
| 2021-06-01 | Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) | +500,000 | 500,000 | D |
| 2021-05-31 | Returned to the company : show line 3 in the form Restricted Stock Award | −1,500,000 | 0 | D |
Loading xslF345X03/ownership.xml…